The existing literature on the relationship between these proteins and preeclampsia is limited, underscoring the importance of further research to elucidate the role of APOC1 and APOL1 in the pathophysiology of preeclampsia and their potential use as biomarkers or therapeutic targets. The gene discussed is APOL1; the disease is preeclampsia.